Brief: Immunocore Announces Publication Of Phase 3 Data Comparing Tebentafusp With Investigator’s Choice

Immunocore Holdings

22/09/2021 23:01

Sept 22 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES PUBLICATION OF PHASE 3 DATA COMPARING
TEBENTAFUSP WITH INVESTIGATOR’S CHOICE IN THE NEW ENGLAND
JOURNAL OF MEDICINE

Source text for Eikon:  ID:nGNE6mcjM3 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))